Open original FDA record ↗Recall record
- FDA identifier
- Z-2321-2026
- Company in FDA record
- Fresenius Medical Care Holdings, Inc.
- FDA classification date
- Jun 5, 2026
- First observed by MedTech Watch
- Nov 16, 2026
- Latest observed content change
- Nov 16, 2026
- Recall classification
- Class II
Reason stated in the source
Given the increased number of leaks reported by users, it was determined to be the appropriate course of action to notify users of the potential for the occurrence of Bicarby luer-lock leaks during manipulation of the frangible and tubing when preparing the product for use for treatment. This issue presents the potential of a slip and fall hazard associated with fluid on the floor.
Source facts
- Action
- On 5/12/2026 an IMPORTANT MEDICAL DEVICE INFORMATION letters were sent to customers to inform them that manipulation of the luer-lock location during treatment preparation may result in fluid spillage onto the user and floor. This occurs prior to treatment and renders the product unusable. Direct contact with the fluid does not present any risk to the user as frangible manipulation only occurs after the peal seam has been broken and the two fluid compartments have been mixed. The potential risk associated with the affected Bicarby Dialysate product is a slip and fall hazard due to the presence of fluid on the floor.
- Initiated
- 2026-05-12
- Root cause
- Process design
- Distribution
- US Nationwide distribution in the states of NY, TN and TX.
- Recall number
- Z-2321-2026
- Recall status
- Open, Classified
- CDRH record ID
- 220066
- FDA classified
- 2026-06-05
- Recall event number
- 98877